The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: tenofovir     Quarter: 2016Q3

Total Records: 439     Number of Pages: 22

DRUGNAME PT EventCount
TENOFOVIR DISOPROXIL FUMARATE. Renal injury 1
TENOFOVIR DISOPROXIL FUMARATE. Renal tubular dysfunction 1
TENOFOVIR DISOPROXIL FUMARATE. Rheumatic heart disease 1
TENOFOVIR DISOPROXIL FUMARATE. Rhinitis allergic 1
TENOFOVIR DISOPROXIL FUMARATE. Sepsis 1
TENOFOVIR DISOPROXIL FUMARATE. Sleep disorder 1
TENOFOVIR DISOPROXIL FUMARATE. Spinal fracture 1
TENOFOVIR DISOPROXIL FUMARATE. Streptococcal bacteraemia 1
TENOFOVIR DISOPROXIL FUMARATE. Supraventricular extrasystoles 1
TENOFOVIR DISOPROXIL FUMARATE. Systemic scleroderma 1
TENOFOVIR DISOPROXIL FUMARATE. Tendon pain 1
TENOFOVIR DISOPROXIL FUMARATE. Testicular torsion 1
TENOFOVIR DISOPROXIL FUMARATE. Tibia fracture 1
TENOFOVIR DISOPROXIL FUMARATE. Ulcer 1
TENOFOVIR DISOPROXIL FUMARATE. Urine phosphorus increased 1
TENOFOVIR DISOPROXIL FUMARATE. Ventricular hypertrophy 1
TENOFOVIR DISOPROXIL FUMARATE. Vulval disorder 1
TENOFOVIR LAMIVUDINE Congenital hydrocephalus 1
TENOFOVIR LAMIVUDINE Foetal exposure during pregnancy 1
TENOFOVIR LAMIVUDINE Maternal drugs affecting foetus 1

Total Records: 439     Number of Pages: 22